Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Filings indexed 525 across all filing types
Latest filing 2025-01-21 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing that Therma Bright has secured a purchase order for medical devices from a distributor. It does not present financial results (so it’s not an Earnings Release), nor does it involve share transactions, dividends, governance, or regulatory/legal disclosures. It is a general business update/announcement, falling into the fallback “Regulatory Filings” category for miscellaneous corporate announcements (RNS).
2025-01-21 English
Material change report - English.pdf
Regulatory Filings Classification · 75% confidence The document is a short notice filed via SEDAR providing the upcoming Annual General Meeting date and record dates. It does not itself contain the AGM materials or proxy statements, nor does it present results or financials. It is a regulatory announcement of corporate event details, fitting the general Regulatory Filings category as a miscellaneous SEDAR notice.
2025-01-13 English
News release - English.pdf
Regulatory Filings Classification · 76% confidence The document is a corporate news release announcing that Therma Bright secured a purchase order for 100 Venowave units from a new distributor. It does not present financial results (Earnings Release), nor is it an Annual or Interim Report, audit, or regulatory filing with accounting details. It is also not about capital/financing, board changes, share transactions, or M&A. It is a general company announcement (press release) delivered via newswire. The most appropriate category in our taxonomy is the fallback “Regulatory Filings” (RNS) for miscellaneous corporate announcements.
2025-01-13 English
Material change report - English.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a NI 51-102F3 Material Change Report describing the issuance of 2,000,000 common shares in settlement of debt. This is an announcement of a capital change (shares for debt issuance), fitting the definition of Share Issue/Capital Change. It is not simply a notice of report publication and not a full annual or quarterly report, but a specific share issuance announcement.
2025-01-10 English
News release - English.pdf
Regulatory Filings
2025-01-09 English
Material change report - English.pdf
Capital/Financing Update Classification · 72% confidence The document is a detailed term sheet/prospectus summary for a structured note issued by TD Bank (a debt instrument linked to a Canadian banks index), describing issuance details, coupon rates, automatic redemption clauses, thresholds, and illustrative calculations. This is not an earnings release, regulatory filing, or annual/quarterly report of the company’s financial performance, nor is it a management presentation or factsheet on company strategy. It is clearly a document relating to a debt issuance – i.e., a financing activity. The most appropriate category is Capital/Financing Update (CAP).
2025-01-04 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.